+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiac Safety Services Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 183 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995402
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiac safety services market is evolving as regulatory demands, digital technologies, and global operations jointly shape new requirements for drug and device development. Senior decision-makers face a complex landscape where integrated risk management and operational efficiency are essential for continued growth and compliance.

Market Snapshot: Cardiac Safety Services Market Growth and Outlook

The cardiac safety services market advanced from USD 1.33 billion in 2024 to USD 1.46 billion in 2025, maintaining healthy momentum with a projected CAGR of 10.03% to reach USD 2.87 billion by 2032. Expansion is steered by proliferating clinical pipelines and the adoption of remote monitoring solutions, while regulatory stringency and integrated risk protocols accelerate market maturity across the healthcare ecosystem. Decision-makers benefit from the market’s resilience to evolving compliance landscapes and ongoing investment in innovative monitoring platforms.

Scope & Segmentation of the Cardiac Safety Services Market

This analysis thoroughly examines the cardiac safety services market, highlighting major industry trends, adoption strategies, and technology innovation. The report segments the sector by service offerings, operational modes, applications, user groups, and international markets, supporting targeted strategic evaluation by senior leaders.

  • Service Types: Highlights include blood pressure measurement, cardiovascular imaging, ECG and Holter measurement, and thorough QT studies. Each service type plays a different role in clinical development and safety evaluation.
  • Type: Distinguishes between integrated and standalone service models, enabling stakeholders to align offerings with core operational needs.
  • Application: Includes use in drug and device development and fulfillment of regulatory compliance requirements, which are essential drivers of demand.
  • End User: Lists contract research organizations, pharmaceutical and biopharmaceutical firms, and research institutes as end users, each contributing distinct expertise and demand profiles.
  • Regions: Covers Americas (North America, Latin America), Europe, Middle East & Africa, and Asia-Pacific, underscoring the need for regional knowledge and global regulatory synchronization.
  • Featured Companies: Key industry players include ACM Global Laboratories, Advarra, Inc., Banook Group, Biotrial, Celerion, Certara, Inc., Charles River Laboratories International, Inc., Circle Cardiovascular Imaging Inc., Clario, Clyde Biosciences Limited, Eurofins Scientific SE, GE HealthCare Technologies Inc., ICON PLC, IQVIA Holdings Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Medpace, Inc., MERIT CRO, Inc., Metrion Biosciences Limited, Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., Parexel International Corporation, PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials.
  • Key Technologies: Digital monitoring platforms, wearable sensors, advanced cardiovascular imaging such as MRI and CT angiography, AI-driven analytics, cloud-based interoperability, and real-time data acquisition frameworks drive innovation in this landscape.

Key Takeaways for Senior Decision-Makers

  • Integrated digital health solutions and advanced analytics have significantly improved the precision of cardiac safety assessments, supporting faster detection and more streamlined workflows.
  • Ongoing global regulatory harmonization reduces compliance complexity, with adoption of standard data formats and risk-based monitoring strategies now widely recognized.
  • Agile service models that encourage cross-functional collaboration between central labs, imaging centers, and electrophysiology units are gaining traction, promoting more cohesive services and rapid decision-making.
  • Contract research organizations and sponsors are increasingly demanding transparent cost structures and robust supply chain resilience, prompting a transformation in vendor selection and long-term partnerships.
  • Expanded investment in cloud infrastructure and AI-powered tools equips market leaders to meet shifting regulatory and operational demands, while maintaining strong quality standards amid continual change.

Tariff Impact on Cardiac Safety Service Supply Chains

Newly introduced United States trade tariffs in 2025 have intensified cost pressures throughout the cardiac safety services supply chain, particularly affecting international sourcing of equipment and consumables. To minimize volatility stemming from these tariff changes, providers are increasingly localizing manufacturing, strengthening domestic collaborations, and refining procurement processes. These approaches enhance service continuity and competitive positioning in a challenging trade environment.

Methodology & Data Sources

This report is grounded in a robust mixed-methods approach, integrating primary interviews from industry experts across contract research organizations, sponsors, and academic institutes with secondary reviews of regulatory guidance and financial filings. Methodical data triangulation and quality controls validate the study’s findings and recommendations.

Why This Report Matters in Cardiac Safety Services

  • Informs strategic planning and resource allocation by clarifying key trends, regulatory changes, and top innovation avenues within cardiac safety services.
  • Assists in evaluating technology investment, selecting suitable partners, and benchmarking vendors to optimize value and industry alignment.
  • Enhances risk management efforts by exposing supply chain vulnerabilities and suggesting practical approaches for procurement in changing policy environments.

Conclusion

The cardiac safety services market is shaped by dynamic regulation, technology evolution, and global economics. Organizations that focus on digital integration, agile service delivery, and cross-sector partnerships will remain positioned for compliance and performance as industry conditions evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of human iPSC-derived cardiomyocyte assays into preclinical safety screening to predict cardiotoxicity
5.2. Expansion of in silico cardiac electrophysiology modeling and simulation under ICH E14 guidance for arrhythmia risk analysis
5.3. Integration of artificial intelligence and machine learning algorithms for automated ECG interpretation in clinical trials
5.4. Growth in outsourced cardiac safety testing services by specialized CROs to navigate regulatory complexity and reduce timelines
5.5. Adoption of organ-on-chip and microfluidic cardiac tissue models for more predictive preclinical safety assessments
5.6. Implementation of remote ECG monitoring and wearable telemetry devices for real-time cardiac safety evaluation in early phase studies
5.7. Development of cloud-based data analytics platforms for centralized cardiac safety data management and risk reporting
5.8. Adoption of translational safety strategies combining translational pharmacokinetics and pharmacodynamics with clinical ECG biomarkers
5.9. Focus on comprehensive proarrhythmia risk profiling using multichannel ECG analysis and beat-to-beat variability metrics
5.10. Utilization of high-throughput automated telemetry screening platforms for efficient cardiac safety assessment in animal studies
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cardiac Safety Services Market, by Service Type
8.1. Blood Pressure Measurement Services
8.2. Cardiovascular Imaging Services
8.3. ECG or Holter Measurement Services
8.4. Thorough QT Studies
9. Cardiac Safety Services Market, by Type
9.1. Integrated Services
9.2. Standalone Services
10. Cardiac Safety Services Market, by Application
10.1. Drug & Device Development
10.2. Regulatory Compliance Requirements
11. Cardiac Safety Services Market, by End User
11.1. Contract Research Organizations
11.2. Pharmaceutical & Biopharma
11.3. Research Institutes
12. Cardiac Safety Services Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Cardiac Safety Services Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Cardiac Safety Services Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. ACM Global Laboratories
15.3.2. Advarra, Inc.
15.3.3. Banook Group
15.3.4. Biotrial
15.3.5. Celerion
15.3.6. Certara, Inc.
15.3.7. Charles River Laboratories International, Inc.
15.3.8. Circle Cardiovascular Imaging Inc.
15.3.9. Clario
15.3.10. Clyde Biosciences Limited
15.3.11. Eurofins Scientific SE
15.3.12. GE HealthCare Technologies Inc.
15.3.13. ICON PLC
15.3.14. IQVIA Holdings Inc.
15.3.15. Koninklijke Philips N.V.
15.3.16. Laboratory Corporation of America Holdings
15.3.17. Medpace, Inc.
15.3.18. MERIT CRO, Inc.
15.3.19. Metrion Biosciences Limited
15.3.20. Ncardia Services B.V.
15.3.21. NEXEL Co., Ltd.
15.3.22. Octagos Health, Inc.
15.3.23. Parexel International Corporation
15.3.24. PhysioStim SAS
15.3.25. PPD, Inc. by Thermo Fisher Scientific Inc.
15.3.26. Richmond Pharmacology Limited
15.3.27. Shanghai Medicilon Inc.
15.3.28. Worldwide Clinical Trials
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Cardiac Safety Services market report include:
  • ACM Global Laboratories
  • Advarra, Inc.
  • Banook Group
  • Biotrial
  • Celerion
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Clario
  • Clyde Biosciences Limited
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • MERIT CRO, Inc.
  • Metrion Biosciences Limited
  • Ncardia Services B.V.
  • NEXEL Co., Ltd.
  • Octagos Health, Inc.
  • Parexel International Corporation
  • PhysioStim SAS
  • PPD, Inc. by Thermo Fisher Scientific Inc.
  • Richmond Pharmacology Limited
  • Shanghai Medicilon Inc.
  • Worldwide Clinical Trials

Table Information